MyAverix Finance
HK · Healthcare
Keymed Biosciences Inc (2162)
Biotechnology
Keymed Biosciences Inc (2162) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $18.72B, P/E ratio is 18.00, net margin is -73.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2162
Keymed Biosciences Inc (2162) — FAQ
What is Keymed Biosciences Inc's market cap?
Keymed Biosciences Inc (2162) has a reported market cap of $18.72B (data as of 2026-05-21).
What is 2162's P/E ratio?
The price-to-earnings (P/E) ratio for Keymed Biosciences Inc (2162) is 18.00 (data as of 2026-05-21).
Does Keymed Biosciences Inc pay a dividend?
Dividend yield is not available in the current snapshot for Keymed Biosciences Inc (2162). Check the MyAverix Finance app for the latest dividend data.
What sector is Keymed Biosciences Inc in?
Keymed Biosciences Inc (2162) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2162 listed on?
2162 is listed on HK.
What is Keymed Biosciences Inc's net margin?
Keymed Biosciences Inc (2162) reports a net margin of -73.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.